Skip to content

Evaluation of the impact of the probiotics-containing dairy product on sleep quality

Evaluation of the impact of the probiotics-containing dairy product on sleep quality - Evaluation of the impact of the probiotics-containing dairy product on sleep quality

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047587
Enrollment
84
Registered
2022-05-09
Start date
2022-05-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Dairy product containing probiotics 1 bottle (100 mL) /day for 8 weeks Dairy product without probiotics 1 bottle (100 mL) /day for 8 weeks

Sponsors

CPCC Company Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Office worker 2. Subjects who are having sleep dissatisfaction 3. Subjects whose average sleep time on weekdays falls in 4 hours or more and 7 hours or less

Exclusion criteria

Exclusion criteria: 1. Subjects who have any clinically significant disease or allergies to foods and drugs which in the investigator's opinion could interfere with the safety of study participants or with the results of the study. 2. Subjects who are currently receiving drug treatment. 3. Subjects who are making an attempt to improve stress, sleep, and fatigue by taking functional foods or receiving therapies. 4. Subjects who are in living condition that can disturb their own sleep. 5. Subjects who have smoking habits. 6. Subjects who daily take excessive alcohol. 7. Subjects who have exercise habits during night time and are unable to finish an exercise by 2 hours before bedtime. 8. Subjects who work on irregular shifts or are engaged in physical labor. 9. Subjects whose sleeping environment is likely to change significantly during the study period due to a long trip or some others. 10. Subjects having skin diseases at where electrodes for EEG measurement are to be applied, or having potential that may cause skin disorders due to the application of the electrodes. 11. Subjects using pacemakers. 12. Females who are pregnant, intend to become pregnant, or breast-feeding. 13. Subjects who have a participation in another interventional clinical study within the last 4 weeks, or are intended to participate. 14. Subjects who have tested positive for SARS-CoV-2 within the last 4 weeks. 15. Others who have been considered ineligible for the participation in the study by the investigator.

Design outcomes

Primary

MeasureTime frame
Subjective sleep feeling measured by the MA version of the OSA sleep inventory

Secondary

MeasureTime frame
Sleep electroencephalography (EEG) Mood questionnaire (VAS) Stress questionnaire (VAS) Pittsburgh Sleep Quality Index

Countries

Japan

Contacts

Public ContactMasanori Numa

CPCC Company Limited Clinical Planning Department

m.n@cpcc.co.jp03-6225-9001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026